Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norrin cystine knot growth factor (NDP) is a secreted, cysteine-rich protein that forms a unique homodimer with each subunit adopting a cystine knot fold[1][2][3]. Norrin functions as an atypical Wnt ligand, activating Wnt/β-catenin signaling specifically through binding Frizzled-4 receptor and Lrp5/6 co-receptors, which is crucial for vascular development in the retina, cochlea, and central nervous system[1][2][3][4]. Mutations in the NDP gene cause Norrie disease and related disorders characterized by retinal vascularization defects, progressive vision loss, and sometimes hearing impairment or intellectual disability[4]. Norrin's role is essential in retinal angiogenesis and the maintenance of blood–retinal barrier integrity. There are no marketed drugs directly targeting Norrin, but its signaling pathway is of significant research interest for inherited vascular diseases of the eye.
Ligand for Frizzled-4 receptor: Binds to Frizzled-4 (Fz4) and co-receptors Lrp5/6, activating the canonical Wnt/β-catenin signaling pathway, promoting vascular development[1][2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norrin cystine knot growth factor (NDP).